Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Durable remission of both multicentric Castleman's...
Journal article

Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV‐8‐positive, HIV‐negative patient

Abstract

WHAT IS KNOWN AND OBJECTIVE: Human herpesvirus-8 (HHV-8)-positive, HIV-negative multicentric Castleman's disease is a rare lymphoproliferative disorder with no standardized treatment. Concurrent Kaposi's sarcoma, another HHV-8-related disease, is uncommon in HIV-negative patients. The role of antiviral therapy and rituximab in HIV-negative patients is not well established. CASE DESCRIPTION: We report a case of a 5-year, durable remission of …

Authors

Murphy C; Hawkes E; Chionh F; Chong G

Journal

Journal of Clinical Pharmacy and Therapeutics, Vol. 42, No. 1, pp. 111–114

Publisher

Hindawi

Publication Date

February 2017

DOI

10.1111/jcpt.12472

ISSN

0269-4727